Erasca Dividends and Buybacks
Dividend criteria checks 0/6
Erasca does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-31.5%
Buyback Yield
Total Shareholder Yield | -31.5% |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Oct 15Erasca: New Focus After Restructuring, But Need More Differentiation
Sep 30Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?
Feb 21We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully
Nov 16Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth
Jun 28We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Jan 20Erasca forms clinical trial partnership with Pfizer for cancer therapy
Oct 20Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Sep 23Erasca adds 10% ahead of R&D Day
Sep 07Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers
Jul 18We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate
Apr 12Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Dec 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ERAS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ERAS's dividend payments have been increasing.
Dividend Yield vs Market
Erasca Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (ERAS) | n/a |
Market Bottom 25% (US) | 1.3% |
Market Top 25% (US) | 4.2% |
Industry Average (Biotechs) | 2.3% |
Analyst forecast (ERAS) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate ERAS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ERAS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ERAS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ERAS has not reported any payouts.